Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | LP-284 |
Synonyms | |
Therapy Description |
LP-284 is an acylfulvene compound that potentially induces DNA double strand breaks and tumor cell apoptosis, leading to inhibition of tumor growth (PMID: 37306526). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
LP-284 | LP284|LP 284 | Chemotherapy - Alkylating 18 | LP-284 is an acylfulvene compound that potentially induces DNA double strand breaks and tumor cell apoptosis, leading to inhibition of tumor growth (PMID: 37306526). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06132503 | Phase I | LP-284 | A Study of LP-284 in Relapsed or Refractory Lymphomas and Solid Tumors | Recruiting | USA | 0 |